Drug-Resistant Infections & the Immediate and Future Demand for Novel Antimicrobials

New Publication!

View the one-page 'takeaways' publication under the Materials section at the top of this webpage.

Webinar for Policymakers

Congressional policymakers, federal policymakers, their advisors, and stakeholders interested in addressing drug-resistant infections and antimicrobial resistance (AMR) are invited to learn about the clinical and public health impact of drug-resistant infections and why policymakers are proposing new incentives for novel antimicrobials. Expert speakers will highlight:

• The current and future threat of drug-resistant infections and antimicrobial resistance
• Market uncertainties that complicate antimicrobial development and commercialization
• Existing and proposed incentives for novel antimicrobials, including the PASTEUR Act

Expected Outcome

Discussion will inform policy approaches that policymakers can leverage to improve the clinical impact, availability, and stewardship of novel antimicrobials.

Expert Speakers

The webinar features the following expert speakers:

• Senator Todd Young, United States Senate
• Helen Boucher, Tufts University School of Medicine 
• Michael Craig, Centers for Disease Control and Prevention 
• Annukka Ojala, European Commission 
• Henry Skinner, AMR Action Fund 

Funding Acknowledgement & Disclosure

This webinar is supported by the AMR Action Fund. The opinions and conclusions expressed or implied are those of the webinar participants and do not necessarily represent the official views of, nor an endorsement, by the AMR Action Fund nor any organization with which webinar participants are/were affiliated.